Clinical features of abnormal α-fetoprotein in 15 patients with chronic viral hepatitis B after treatment with antiviral drugs

Table 1 Baseline clinical data of 15 patients with chronic hepatitis B combined with elevated -fetoprotein

No.	Sex	Age	ALT	AST	TBIL	ALP	GGT	TBA	ALB	AFP	ANA	IgG	HBV-DNA
1	Female	62	29.9	41.3	8.9	98.9	281.7	24.5	41.4	29.77	1: 320	18.73	30.8
2	Male	48	61.9	100.3	27	114.4	57.5	82.6	27.9	32.96	-	30	-1
3	Male	56	35.7	44	58.6	140.9	106.8	78.3	27.9	19.36	-	25.1	-1
4	Female	64	77	69.7	24.3	143.7	100.1	67.9	25.9	142.96	-	34.7	6.49 × 103
5	Male	57	34.5	50.3	46.5	92	93.3	299.5	29.8	85.75	-	26	-1
6	Female	57	28.5	65	44.5	149.9	185.8	45.6	25	77.42	1: 160	21.15	1.27 × 102
7	Male	67	15.5	21.8	18.8	71.8	48	34.8	34	8.47	<1: 80	21.8	-1
8	Male	57	22.7	57.2	20.1	107.7	46.2	39.7	33	42.99	<1: 80	28.03	5.48 × 102
9	Male	60	34.3	66	45.8	157.8	92	60.9	24.1	18.56	-	22.32	-1
10	Female	69	20.6	27	12.6	178.5	41	2	22.3	14.28	<1: 80	25.23	-1
11	Female	51	39.5	35	17.2	73.1	51	33.5	40.3	6.85	<1: 80	20.27	3.06 × 102
12	Male	49	24.7	30	33.1	111.1	134	3.8	28.8	340.1	<1: 80	19.89	51.5
13	Male	52	36.4	104	50.5	148.8	179	12.5	36.9	1004	<1: 80	24.48	5.24 × 103
14	Male	57	72.6	63	8.1	59.1	48	70.8	40.5	158.3	<1: 80	22.04	-1
15	Male	50	24	32	30.3	123.7	65	8	35.1	10.69	<1: 80	25.27	-1

¹Hepatitis B virus DNA level below lower limit of detection.

ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; TBIL: Total bilirubin; ALP: Alkaline phosphatase; GGT: Gamma-glutamyltransferase; TBA: Total bile acid; ALB: Albumin; AFP: Alpha fetoprotein; ANA: Antinuclear antibody; HBV-DNA: Hepatitis B virus DNA.